-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Epetirimod
Category | Human papillomavirus (HPV) |
CAS | 227318-71-0 |
Description | Epetirimod is a small-molecule immune-response modifier intended for the topical treatment of cervical human papilloma virus (HPV) infection and cervical dysplasia. |
Product Information
Synonyms | Epetirimod;227318-71-0;UNII-9P5MH9F521;Epetirimod [USAN:INN];851A;S-30563;9P5MH9F521;1-(2-Methylpropyl)-1H-imidazo(4,5-c)(1,5)naphthyridin-4-amine;1-(2-methylpropyl)imidazo[4,5-c][1,5]naphthyridin-4-amine;1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine;851-A;1H-Imidazo(4,5-c)(1,5)naphthyridin-4-amine, 1-(2-methylpropyl)-;S 30563;Epetirimod [USAN];EPETIRIMOD [INN];Epetirimod (INN/USAN);SCHEMBL544542;CHEMBL2103807;DTXSID20177268;UCPMSMNKGXUFCC-UHFFFAOYSA-N;AKOS040751696;TS-08718;D08911;Q27272855; |
IUPAC Name | 1-(2-methylpropyl)imidazo[4,5-c][1,5]naphthyridin-4-amine |
Molecular Weight | 518.5 |
Molecular Formula | C23H18F4N6O2S |
Canonical SMILES | CCC1=CC2=C(C=C1F)C(=C(N2C3=NC=CC=N3)C4=NC=C(C=C4)S(=O)(=O)N[C@@H](C)C(F)(F)F)C#N |
InChI | InChI=1S/C13H15N5/c1-8(2)6-18-7-16-11-12(18)10-9(17-13(11)14)4-3-5-15-10/h3-5,7-8H,6H2,1-2H3,(H2,14,17) |
InChIKey | UCPMSMNKGXUFCC-UHFFFAOYSA-N |
Purity | >98% |
Appearance | Solid powder |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |